Experimental Hypofibrinogenemia by Pifer, Paul W. et al.
Henry Ford Hospital Medical Journal
Volume 3 | Number 3 Article 2
9-1955
Experimental Hypofibrinogenemia
Paul W. Pifer
Melvin Block
C. Paul Hodgkinson
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health
Commons
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry
Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact
acabrer4@hfhs.org.
Recommended Citation
Pifer, Paul W.; Block, Melvin; and Hodgkinson, C. Paul (1955) "Experimental Hypofibrinogenemia," Henry Ford Hospital Medical
Bulletin : Vol. 3 : No. 3 , 112-118.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol3/iss3/2
EXPERIMENTAL HYPOFIBRINOGENEMIA 
I . Studies on Trauma, Amniotic Fluid Infusion, and Incompatable Blood Transfusion. 
PAUL W.PIFER, M.D.,* M E L V I N BLOCK, M.D., ' C. PAUL HODGKINSON, M.D.* 
To acquire additional knowledge about the behavior of blood plasma fibrinogen 
incident to trauma, a series of experimental observations were made using dogs and 
rabbits. Corollary studies were made on the clotting behavior and clotting constituents 
of blood following infusion of amniotic fluid, placental extracts in amniotic fluid, and 
heterologous blood. 
Similar studies were initiated by Foster and Whipple in 1922.'-2,3 Elevated plasma 
fibrinogen concentrations were observed by them following trauma and inflammation. 
Depressed fibrinogen values occurred incident to acute chloroform hepatitis and blood 
transfusions in dogs. The fibrinogen utilization influence of slow thromoplastin infusions 
was observed by Fulton and Page,'' Ratnoff and Conley,^ and others.*'^  As a result 
of these observations thromboplastinemia has been assumed to be the causative factor 
for depressed fibrinogen values following trauma in experimental animals and surgery 
in humans.8''''° 
Abruptio placentae,"''2 prolonged intrauterine retention of a dead fetus,^ 3,14 and 
ammniotic fluid embolism'^js at times have been complicated by critical failure of the 
coagulation process.^  The massive converersion of fibrinogen to fibrin results in utiliza-
tion of the plasma fibrinogen with the precipitation of insoluble fibrin gel. This, balanced 
against the ability of the liver to re-supply fibrinogen to the circulating blood plasma, 
affords dynamic import to serial blood plasma fibrinogen samples procured incident 
to a thromboplastin insult. Thus, with other factors controlled, sudden fibrinogen de-
pression followed by prompt recovery is suft'iciently characteristic to support the sus-
picion of hyperthromboplastinemia; and, the identification of incidence and the deter-
mination of degree of thromboplastin induced fibrinogen-fibrin conversion is measur-
able by observing the yardstick of serial plasma fibrinogen assays. 
Realization that the circulatory system may be flooded with insoluble fibrin follow-
ing surgery and trauma is thought-provoking. Its relationship to the subsequent 
development of ph'.ebcthrombosis gains more rational theoretical importance when one 
appreciates that the circulation is flooded by a phase of insoluble fibrin gel. Knisely,''^ 
in his studies on sludged blood, observed a sticky substance, "possibly fibrin," on 
the endothelial surface of blood vessels as the initial incident of sludging. The clinical 
magnitude of the process varies from insignificance to irreversible shock. 
The relation of the defibrinating process of intravascular thromboplastin-induced 
fibrinogen-fibrin conversion to such conditions as acute hemorrhagic pancreatitis, crush 
injuries, burns and obscure hemorrhage, and thrombosis is speculative and will require 
further investigation. 
In this project two phases of this morbid physiological process were studied: 
1. Fibrinogen changes experimentally produced by trauma and simulated ob-
stetric conditions. 
2. Fibrinogen and other blood coagulation constituents following infusion of 
heterologous blood (incompatible blood transfusions). 
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Method: 
The experiments were performed upon adult dogs and rabbits using ether anes-
thesia for dogs and intravenous sodium pentobarbitrate for rabbits. Blood specimens 
were obtained by one investigator who was careful to observe similar technic both 
in the procurement method and handling of the blood specimens. Plasma fibrinogen 
was determined by the Wu-Ling method, the normal range being 200 to 400 mgm. per 
100 cc plasma.'7 
Following procurement of the initial control blood specimen, blood sampling 
was performed at frequent, but variable, time intervals, on the experiment day. If 
the animal survived, blood specimens were obtained on subsequent days. 
In the transfusion experiments, the following additional determinations were done: 
hemoglobin, (electro photometer) coagulation time, (Lee White),18 bleeding time, 
(Duke method)!' prothrombin time, (Quick),2° and platelet count (Rees-Ecker 
method) .21 
Results: 
a. Control experiments. 
Two dogs and two rabbits were studied to determine the effects of several 
hours of anesthesia on the plasma fibrinogen concentration. Serial platelet 
counts were done on one dog. As can be observed in chart No. 1, no significant 
changes in either blood fibrinogen concentration or platelets were observed. 
Time 
0 
30' 
60' 
1 hr. 
1:30 
2 hr. 
2:30 
3 hr. 
3:30 
4 hr. 
Time 
0 
45-
75' 
105' 
onset anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
onset anesthesia 
during anesthesia 
during anesthesia 
during anesthesia 
Table I — DOG 
Anesthesia 
Fibrinogen Mgm per lOOcc Plas:na 
272 
272 
280 
282 
2V7 
291 
clot 
287 
291 
278 
Anesthesia 
Platelet Count 
240,000 
200,000 
208,000 
205,000 
Trauma experiments. 
Various degrees of trauma were induced. In general, the fibrinogen de-
creased in value and degree according to the amount and degree of acute 
cellular catabolic effect induced by trauma. 
In dogs and rabbits consistent and considerable fibrinogen depression 
followed severe leg trauma caused by hammer blows. Less alteration in fib-
rinogen concentration foflowed evisceration and vascular ligation procedures. 
Rabbits appeared to be more sensitive to the effects of trauma. The data are 
summarized in Tables No. 2 and No. 3. 
Simulated obstetric conditions. 
To simulate amniotic fluid embolism, 5cc of clear amniotic fluid was 
injected into the femoral vein of a pregnant dog at term. No gross effect 
was apparent. Fifteen minutes later, 7cc of a placental-amniotic fluid extract, 
strained through gauze, was injected into the femoral vein of the animal. 
113 
Within 30 seconds, labored respirations occurred, followed by rigidity and 
apnea in 90 seconds. One minute later cardiac function ceased. The pre-experi-
mental fibrinogen level was 339 mgm. per lOOcc plasma, and at the time of 
death, was 98 mgm. per lOOcc plasma. The placenta and amniotic fiuid were 
obtained from the right horn of the animal's own uterus. Autopsy revealed 
no gross changes in the lungs. 
Table I I 
Plasma Fibrinogen Values-
A N I M A L OPERATION Control Value mgm per 100c plasma 
Dog Leg tourniquet 0 time 31)- 60- 90' 120' 150' 180' 210' 
279 257 284 Clot 276 272 276 285 
Dog Leg Trauma 0 time 15' 45' 75' 105' 135' 165' 195' 
Hammer Blows 280 274 267 267 267 280 253 259 
Dog Aortic Graft 0 time 40' 70' 100' 155' 185' 240' 
Procedure 273 273 246 267 244 253 244 
Ligation 0 tim.e 30' 60- 90' 120' 150' 180' 210' 
Dog Renal 
Pedicles 254 253 223 226 244 239 262 246 
Dog Phlebotomy—500cc 0 time 15' 45' 85' 115' 140' 150' 180' 
& Re-transfusion 298 285 260 270 267 2'- •• 292 Clot 
Dog Phlebotomy—500cc 0 time 5' 65' 65- 125' 185' 240' 
& Re-transfusion 278 255 260 201* 255 266 244 
Occlusion 0 time 5i l ' 70' 100' 130' 160' 220' 
Dog Hepatic 
Circulation 215 Clot 237 237 237 244 233 
Ligation Renal 0 time 45' 85' 100' 115' 130' 145' 160' 
Dog Vessels and 
Evisceration 249 252 244 267 249 247 226 264 
Rabbit Leg Trauma 0 time 30' 45' 160' 
Few Hammer Blows 242 233 221 233 
Rabbit Leg Trauma 0 time 30' 90' 
Many Hammer Blows 258 179 167 
Rabbit Leg Trauma 0 time 40' 55' 75' 105' 
250 Blows 356 322 256 330 320 320 
240' 
287 
225' 
265 
24 hrs. 48 hrs. 
255' 
267 
280' 
295 295 
283 
273 328 
(•^ Specimen from blood collected—followed by immediate re-transfusion.) 
Table I I I 
EVISCERATION 
Fibrinogen mgm/lOOcc Plasma 
307 
Time 
0—Control 
20' 
50-
80' 
110' 
140' 
170' 
200' 
230' 
Expired 250' 
255' 
285 
280 
304 
310 
309 
304 
278 
276 
297 
292 
IV Table 
Experiment XIV September 29, 1954 
AMNIOTIC FLUID 
Pregnant Dog 
Time 
8:45 A.M. 
9:30 A.M. 
10:00 A.M. 
10:30 A.M. 
11:00 A.M. 
No. 1 Control 
Kilo 
Fibrinogen 
339 
322 
315 
302 
98 
114 
Other experiments were performed using amniotic fluid, meconium sus-
pension in amniotic fluid, placental extracts, and fibrinolysin (bovine). The 
results are summarized in Table No. 5. 
Table V 
Simulated Obstetric Conditions 
Animal Injectant Origin of Quan. Control Fibrinc gen Values —mgm/lOOcc 
Injectant Value Plasma Comment 
Rabbit Amniotic Human 0 time 60- 120' 180' 
Fluid (fresh) 5cc 115 185 181 181 
Rabbit Amniotic Human 0 time 10' 55' 140' 
Fluid (7 day old) lOcc 170 160 160 110 
Rabbit Amniotic Human 0 time 10' Expired 3' 50' 
Fluid (fresh) 5cc 183 139 following injection 
Rabbit Meconium Human 0 time 15' 45' 85' 140' 195' 
1 cc 296 253 259 253 244 249 
Rabbit Meconium Human 
5cc 
0 time 
158 
10' 
145 
Expired 30" 
following injection 
Rabbit Meconium 
& amniotic 
Rabbit 0 time 35' 55' 75' 
fluid Vice 280 180 286 259 
Rabbit Placental Human 0 time 17' 32' 50' 105' 165' 
Extract 2cc 369 421 3.^ 4 332 .323 295 
Rabbit Placental Rabbit 0 time r Animal 
Extract (same 
animal) 
5cc 260 270 Expired 60" 
following injection 
Rabbit Fibrinolysin Bovine lOOu 0 time 30' 60- 90- 150' 
(8cc) 162 155 148 141 119 
Rabbit Fibrinolysin Bovine lOOu 0 time 25' 45' 75' 105' 135' 165' 
(5cc) 334 316 309 296 270 270 259 
II. Incompatable Blood Infusions. 
In these experiments, dogs were administered rabbit's blood, and rabbits received 
dog's blood. The quantity administered varied from 10 to 30 per cent of the estimated 
blood volume. The rate of infusion varied from a slow drip to free flow. In addition 
to depression of plasma fibrinogen, bleeding time was prolonged, clotting time pro-
longed or completely prevented, platelets critically diminished and prothrombin time 
unchanged. The results of a typical experiment are shown in Table No. 6 of a dog 
which received 350cc of rabbit blood. 
Table V I 
Incompatible Blood Transfusion 
(Rabbit blood to Dog) 
350cc 
Time Hb Bleeding Coagulation Platelet Prothrombin Fibrinogen 
Time Time Count Time 
L 0 17.7 50" 10' 178,000 8" 173 
Bleeds f rom 
12- Control None in 2 Hrs. 18,000 10" 142 
Bleeds f rom 
27' 15.0 Control None in 2 Hrs. 24,000 12" 121 
Bleeds f rom 
57- Control 34' 27,000 11.5" 128 
90' 12- 132 
120' 13.4 2' 9" 7 39,000 11" 123 
150' 66,000 10" 133 
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Chart I shows the fibrinogen and platelet alterations in a dog resulting from three 
blood infusions. The first infusion consisted of 300cc rabbit blood, the second was 
400cc dog blood 12 days later, and the third infusion given 12 days later (25 days 
from the initial infusion of rabbit's blood) was lOOcc rabbit blood. The animal ex-
pired within 24 hours following the last blood infusion. The contrasting results follow-
ing administration of heterologous and homologus blood are strikingly demonstrated in 
this animal. Althrough the fibrinogen and platelet changes are less in the third phase of 
this experiment, the volume of heterologous blood administered was reduced by two-
thirds. The physical changes apparent from the effects of the heterologous blood were 
of considerable magnitude in the first and third experiment. 
CHART 1 
Tab le VII 
INCOMPATIBLE BLOOD T R A N S F U S I O N 
Dog 0 
Plotelet 
count 
200 ,000 
150,000 
100,000 
5 0 , 0 0 0 
COMMENT 
Trauma: 
In the laboratory animals studied, fibrinogenopenia incident to trauma exhibited 
quaUtative properties. In practically all experiments fibrinogen plasma values decreased, 
but the degree of fall was not always quantitative. Nor was the fibrinogen depression 
always proportionately related to the degree of shock exhibited in the animal. Shock 
from intestinal manipulation resulted in slight fibrinogen depression. Cell destruction 
incident to hammer blows to the leg resulted in considerable fibrinogen depression. 
These observations were consistent with the experience of others.^ Foster and 
Whipple''2,3 considered cell injury the most potent factor to influence plasma fibrinogen. 
In the laboratory experimental results appeared to be influenced by animal species 
variation. Rabbits were more susceptible to trauma than dogs. In rabbits the amount 
of fibrinogen depression tended to be proportional to the amount of trauma. Experi-
mental animals, like man, exhibit post trauma hyperfibrinogenemia. 
Amniotic Fluid Infusion 
When extracts of placental tissue in saline or amniotic fluid were injected, symptoms 
of pulmonary insufficiency and critical fibrinogen depression followed. 
Less consistent results were observed to follow infusion of amniotic fluid, meconium 
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suspensions, and combinations of these two. Fibrinogen usually was depressed, but 
the degree varied from animal to animal. Repeated injections of amniotic fluid and 
meconium appeared to be associated with fewer symptoms upon subsequent injections 
suggesting the development of an imm.une reaction. 
Bovine fibrinogen injected intravenously caused plasma fibrinogen depression. 
Infusion Heterologous Blood 
Incompatible blood infusions resulted in rather consistent findings. Most striking, 
was the precipitous fall in platelet count which occurred almost immediately following 
infusion of blood. Platelet depression was followed in a few hours by gradual re-
stitution toward normal. 
Hemoglobin concentration was observed to fall slightly for a short period of time 
following onset of infusion. 
The coagulation time was greatly increased immediately following onset of blood 
infusion. Frequently, the blood failed to clot within a 24 hour period. Coagulation 
failure was of short duration and usually within two hours, blood was observed to 
clot normally. 
Plasma fibrinogen values were consistently reduced but seldom to human critical 
levels. Twenty-four hours following the experiment plasma fibrinogen was observed 
to be present in concentrations greater than before the experiment. 
The prothrombin time was normal in all experiments. 
Gross homolysis occurred. A hemorrhagic diathesis usually was evident for a 
short, variable period of time immediately following the infusion of blood. Bleeding 
time was prolonged during these periods of time. 
AU these observations were affected by the speed of the transfusion. Given rapidly, 
the above symptoms appeared promptly in a vigorous reaction. Given slowly, symp-
toms were detected with difficulty and sometimes not at all. 
Homologous, untyped animal blood presented no symptoms or findings suggestive 
of disturbed homeostasis. 
Repeated infusions of heterologous blood, in one animal, caused symptoms 
suegestive of anaphylactoid shock. 
Summary and Conclusions. 
A series of animal experiments are reported in which the plasma fibrinogen value 
was studied under conditions simulating trauma and certain obstetric conditions. 
Fibrinogen concentration in the blood plasma was generally observed to be depressed 
under these experimental conditions. 
The administration of heterologous blood caused critical depression of the blood 
platelets and less critical fibrinogen depression. Findings were observed to vary directly 
with the speed of the administration. These findings suggested that the reaction ob-
served following the administration of mismatched blood assumed the pattern usually 
observed foflowing the experimental intravenous administration of thromboplastin. 
It appears likely that, in experimental animals, platelet depression may serve as a 
more delicate indicator for evidence of thromboplastinemia than fibrinogenopenia. 
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